BioMarin to Present at the J.P. Morgan Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BioMarin Pharma (BMRN) Chair Lapalme to Step Down; Will Restructure Board Makeup
January 7, 2015 4:20 PM ESTBioMarin Pharma (NASDAQ: BMRN) announced that, after a tenure of more than a decade, Pierre Lapalme has elected to step down as Chairman of the Company's Board of Directors following the annual meeting of stockholders anticipated in June of this year. Mr. Lapalme will seek re-election to serve as a Director on BioMarin's Board at the meeting. Mr. Lapalme joined BioMarin's Board of Directors in January 2004 and was named as Chairman of the Board in August 2004.
Following Mr. Lapalme's decision, the Board elected to revise the organizational structure of the Board... More
